In conclusion, lung adenocarcinoma negative for mutant p53 was presumed to have a good prognosis, but when the expression of mutant p53 was investigated in combination with CSC markers, the prognosis of these patients was better with statistical significance. The gene discussed is TP53; the disease is lung adenocarcinoma.